Point of Care MatMaCorp's MYRTA handheld real-time PCR device enables over-the-counter and point-of-care molecular diagnostics for human and animal health, creating sales opportunities with clinics, urgent care centers, pharmacies, veterinary practices, field testing services, and food-safety QA labs seeking portable, equipment-free testing with rapid results. The solution's elimination of refrigerators, centrifuges, and pipettes expands addressable markets in rural and mobile testing environments.

Govt Health Partnerships Existing collaborations with NIH and DHS position MatMaCorp to pursue federal, state, and regional health surveillance and biodefense programs. Sales opportunities include hospital networks receiving grants, Midwest health systems, public health agencies, and agriculture biosecurity programs for rapid outbreak detection and disease surveillance, leveraging NIH funding and deployment experience to scale adoption.

Animal and Farm Animal health and food production are core markets, including veterinary clinics, livestock producers, and processing facilities needing on-site PCR testing for disease surveillance and food-safety compliance. Capabilities relevant to African swine fever and other pathogens align with contract opportunities across farm operations and supply chains, enabling multi-site deployment.

Channel Partnerships To accelerate adoption, prioritize distributor and integrator partnerships, OEM licensing, and service contracts that provide training, maintenance, and consumables. The portable device supports rental or capex-to-opex models for large institutions and regional health networks, expanding the sales motion beyond direct selling to channel partners.

Global Readiness The portable, low-resource-friendly design positions MatMaCorp for international expansion into low-infrastructure settings, disaster response, and mobile clinics, aligning with market trends toward rapid diagnostics and decentralized testing. Target international aid agencies, non-profits, and emerging markets where traditional lab infrastructure is impractical.